COVID-19: Mayo Clinic is committed to taking care of our patients, learners and staff. Learn more about attendance requirements for live courses and conferences and available COVID-19 online education and resources.

This monthly Grand Rounds program is aimed at topics which align with Mayo Clinic's position as a global leader in research and education, the professional interests of participants in London and the importance of sharing knowledge on timely topics/issues.

Future Webinars for Mayo Clinic Healthcare London Grand Rounds Series 

Session 3:  Mayo Clinic Healthcare London Grand Rounds - Gastrointestinal
Tuesday, June 28, 2022 12:30 - 1:30 p.m. CT / 6:30 - 7:30 p.m. BST

In this one-hour no-cost Grand Rounds session from Mayo Clinic Healthcare in London, our experts will discuss colorectal cancer development and new techniques to enhance detection and resection of serrated polyps, as well as endoscopic management of bariatric and metabolic disorders.

  • Moderator: Lois Krahn, M.D.
  • Featured expertNavtej (Nav) S. Buttar, M.D., consultant, Division of Gastroenterology and Hepatology, Mayo Clinic; professor of medicine, Mayo Clinic College of Medicine and Science
  • Featured expertJames East, M.D., senior associate consultant, Gastroenterology, Mayo Clinic Healthcare; associate professor, John Radcliffe Hospital, University of Oxford 
 

Session 4:  MCH London Grand Rounds - Advancing The Paradigm: Personalized Genomic Approach to Breast Cancer Risk Assessment- Impact on Screening and Prevention​​​​​​​
Tuesday, July 12, 2022 12:30 - 1:30 p.m. CT / 6:30 - 7:30 p.m. BST

In this one-hour no-cost Grand Rounds session from Mayo Clinic Healthcare in London, our experts will discuss breast cancer risk assessment, which entails understanding clinical and genomic risk factors. Available risk calculation models provide population level risk with limitations in implementation in clinical practice. We need to advance the paradigm and transition to precision prevention and personalized risk stratification. With accurate risk assessment clinicians can optimize clinical benefits including surveillance imaging and risk reducing medication options. New research on the use of single nucleotide polymorphisms and polygenic risk score could be useful for stratifying and predicting individualized breast cancer risk and enhance shard decision making opportunities in management of women at increased risk for breast cancer.

  • Moderator: Lois Krahn, M.D.
  • Featured expert: Sandhya Pruthi, M.D.
Next Expected Session(s) sign up to be notified of these and future Mayo Clinic Healthcare London Grand Rounds Series

Session 5: September, 2022 


 Notify Me of Future Webinars 


Mayo Clinic Healthcare London Grand Rounds Series

Live Webinar - CLAIM CME CREDIT
Pre-Recorded Online CME Course

    Session 2: Mayo Clinic Healthcare London Grand Rounds - Management of Left Main Coronary Artery Disease
    Wednesday, May 11, 2022  12:30 - 1:30 p.m. CT / 6:30 - 7:30 p.m. BST 
    Left main coronary artery (LMCA) disease can have life-threatening consequences for adults of all ages. Management decisions can play a significant role in providing the best long-term benefit for patients, while mitigating the risks related to revascularization. In this one-hour webinar from Mayo Clinic Healthcare in London, our experts will discuss a pragmatic approach for shared decision-making for patients with LMCA disease.

    • Featured expert: Malgorzata Wamil, M.D.
    • Featured expert: Gurpreet Sandhu, M.D.

    Live Webinar - CLAIM CME CREDIT
    Pre-Recorded Online CME Course

    Session 1:  Mayo Clinic Healthcare London Grand Rounds - The Latest on Covid-19 Advances March 1, 2022 
    This monthly Grand Rounds program was aimed at topics which align with Mayo Clinic's position as a global leader in research and education, the professional interests of participants in London and the importance of sharing knowledge on timely topics/issues.

    • Moderator and Featured Expert: Sanjay Prasad, M.D.
    • Featured expert: Gregory Poland, M.D.
    • Featured expert: Abinash Virk, M.D.